Stockscreener 앱 받기
2.77
1.95%
0.02
전일 마감가:
$2.75
열려 있는:
$2.76
하루 거래량:
61,771
Relative Volume:
0.14
시가총액:
$289.33M
수익:
$7.05M
순이익/손실:
$-30.43M
주가수익비율:
-7.3126
EPS:
-0.3788
순현금흐름:
$21.84M
1주 성능:
-1.97%
1개월 성능:
+14.44%
6개월 성능:
+40.89%
1년 성능:
-24.83%
1일 변동 폭
$2.71
$2.81
1주일 범위
$2.60
$3.00
52주 변동 폭
$1.07
$4.21
Proqr Therapeutics N V Stock (PRQR) Company Profile
PRQR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRQR
Proqr Therapeutics N V
|
2.75 | 289.70M | 7.05M | -30.43M | 21.84M | -0.3788 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.54 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.38 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-04-29 | 개시 | Evercore ISI | Outperform |
| 2025-03-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-01-10 | 개시 | Oppenheimer | Outperform |
| 2024-10-29 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-11-08 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2023-03-30 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-12-22 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-02-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-11 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2022-02-11 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-02-01 | 개시 | Raymond James | Strong Buy |
| 2021-05-03 | 개시 | Stifel | Buy |
| 2021-03-25 | 재확인 | Citigroup | Buy |
| 2020-11-03 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-03-12 | 재확인 | Chardan Capital Markets | Buy |
| 2018-12-19 | 개시 | RBC Capital Mkts | Outperform |
| 2018-11-15 | 개시 | Citigroup | Buy |
| 2018-09-19 | 개시 | Evercore ISI | Outperform |
| 2017-09-26 | 재확인 | JMP Securities | Mkt Outperform |
| 2016-06-20 | 개시 | Chardan Capital Markets | Neutral |
| 2014-10-15 | 개시 | Deutsche Bank | Buy |
| 2014-10-13 | 개시 | H.C. Wainwright | Buy |
모두보기
Proqr Therapeutics N V 주식(PRQR)의 최신 뉴스
Will ProQR Therapeutics N.V. stock gain from government policiesMarket Volume Report & Stock Timing and Entry Methods - newser.com
Earnings visualization tools for ProQR Therapeutics N.V.2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - newser.com
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Up 80.2% in October - Defense World
Will ProQR Therapeutics N.V. stock outperform international peersMarket Activity Recap & Precise Buy Zone Tips - newser.com
Is ProQR Therapeutics N.V. stock a good choice for value investorsPortfolio Update Report & Reliable Price Breakout Alerts - newser.com
Key metrics from ProQR Therapeutics N.V.’s quarterly dataMarket Risk Summary & Safe Swing Trade Setup Alerts - newser.com
How sentiment analysis helps forecast ProQR Therapeutics N.V.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
What catalysts could drive ProQR Therapeutics N.V. stock higherDay Trade & Weekly Top Stock Performers List - newser.com
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Update - MarketBeat
Custom watchlist performance reports with ProQR Therapeutics N.V.Bear Alert & Verified Trade Idea Suggestions - newser.com
What’s the recovery path for long term holders of ProQR Therapeutics N.V.July 2025 Snapshot & Daily Profit Focused Screening - newser.com
Is ProQR Therapeutics N.V. stock attractive for growth ETFsJuly 2025 Technicals & Community Supported Trade Ideas - newser.com
ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Visualizing ProQR Therapeutics N.V. stock with heatmapsTrade Entry Summary & Long Hold Capital Preservation Tips - newser.com
Is ProQR Therapeutics N.V. stock cheap at current valuationJuly 2025 PostEarnings & Precise Buy Zone Identification - newser.com
ProQR Therapeutics NV expected to post a loss of 10 cents a shareEarnings Preview - TradingView
ProQR Therapeutics (PRQR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Why analysts recommend ProQR Therapeutics N.V. (0PQ) stockMarket Volume Report & Entry Point Confirmation Signals - newser.com
Does ProQR Therapeutics N.V. stock trade at a discount to peersBreakout Watch & Low Risk High Win Rate Picks - newser.com
Is ProQR Therapeutics N.V. (0PQ) stock at risk of policy regulation2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
ProQR Therapeutics (NASDAQ:PRQR) Stock Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat
Proqr Therapeutics N V (PRQR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.03%
0.32%
자본화:
|
볼륨(24시간):